|
|
|
|
Serina Therapeutics Inc (NYSE: SER) |
|
Price: $4.7100
$-0.05 
-1.050%
|
| Day's High:
| $4.8
| Week Perf:
| -0.21 %
|
| Day's Low: |
$ 4.70 |
30 Day Perf: |
-10.29 % |
| Volume (M): |
6 |
52 Wk High: |
$ 14.57 |
| Volume (M$): |
$ 30 |
52 Wk Avg: |
$7.30 |
| Open: |
$4.77 |
52 Wk Low: |
$3.81 |
|
|
| Market Capitalization (Millions $) |
51 |
| Shares
Outstanding (Millions) |
11 |
| Employees |
- |
| Revenues (TTM) (Millions $) |
0 |
| Net Income (TTM) (Millions $) |
-9 |
| Cash Flow (TTM) (Millions $) |
-5 |
| Capital Exp. (TTM) (Millions $) |
0 |
Serina Therapeutics Inc
Company Address: 601 Genome Way Huntsville 35806 AL
Company Phone Number: 327-9630 Stock Exchange / Ticker: NYSE SER
|
|
|
|
|
|
|
| Stock Performances by Major Competitors |
|
|
|
| Stocks on the Move
Published Tue, Jul 9 2024 3:15 PM UTC
Word Count: 685The under-performance of Serina Therapeutics Inc shares this week can be attributed to a series of events that have impacted the company s stock performance. Despite recent market volatility and insider trading activities, there are lingering opportunities for the biotech company to rebound in the future.One significant event that affected Serina Therapeutics ...
|
| Per Share |
Current |
| Earnings (TTM) |
-8.66 $ |
| Revenues (TTM) |
0.02 $
|
| Cash Flow (TTM) |
- |
| Cash |
0.3 $
|
| Book Value |
-
|
| Dividend (TTM) |
0 $ |
|
|
| Per Share |
|
| Earnings (TTM) |
-8.66 $
|
| Revenues (TTM) |
0.02 $ |
| Cash Flow (TTM) |
- |
| Cash |
0.3 $
|
| Book Value |
- |
| Dividend (TTM) |
0 $ |
|
|
|
|
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.
Copyright © 2025 CSIMarket, Inc. All rights
reserved.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
3.13%